Medication Labeling, Storage, and Refrigerator Monitoring Failures
Summary
The facility failed to follow its medication labeling and storage procedures in two medication carts, a treatment cart, and a medication refrigerator. During observation of the cart for rooms 1 through 12, R42’s Lantus vial had the seal off and no date on the vial or box, R50’s albuterol inhaler was not dated and had no pharmacy label, R19’s Trelegy Ellipta inhaler was not dated, and R28’s ketorolac injection bottle was open and returned to the cart with no open date. In the cart for rooms 13 through 20, R3’s Lyumjev insulin vial had the top removed with no date on the vial or box, R35’s Stiolto Respimat inhaler and a Ventolin HFA inhaler were not dated, opened blood sugar sticks were not dated, R8’s albuterol inhaler was not dated, and R10’s ipratropium nasal spray and R40’s fluticasone nasal spray were opened without dates on the bottle or box. The treatment cart was observed unlocked in the hallway, allowing access to ointments and creams. Inside were opened and used products including R36’s diclofenac topical gel, R12’s hydrocortisone cream, and R20’s mupirocin ointment, all without open dates on the tubes or boxes. Staff stated the treatment cart is usually open and used by nurses, while the DON acknowledged that the treatment cart should be locked when not in use. The DON also stated that multi-dose vials, pens, and containers should be dated when opened because they must be discarded within 30 days or earlier per pharmacy recommendations or manufacturer guidance. In the medication room refrigerator, the temperature log had missing entries for 12/8/25 and 12/9/25, despite the facility’s log requiring temperatures to be checked and recorded at least twice daily. The refrigerator also contained multiple opened and undated items, including floor stock Afluria influenza vaccine, R37’s lorazepam injectable vial with the seal off and no date on the vial or bag, and an opened pneumonia vaccine syringe with the cap removed and no date. The DON could not provide a date for when R37’s lorazepam vial had been opened and used, and record review showed the medication had been received in 11/2024 and last signed out in 2/2025, yet remained in the refrigerator opened and used for over a year. The facility’s multi-dose vial policy stated that opened vials are to be relabeled with a beyond-use date 28 days after opening and include the initials of the nurse who opened the vial.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.